ExLibris header image
SFX Logo
Title: New approaches to molecular cancer therapeutics
Source:

Nature Chemical Biology [1552-4450] Collins, Ian yr:2006


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Helleday, T. "DNA repair pathways as targets for cancer therapy." Nature reviews. Cancer 8.3 (2008): 193-204. Link to Full Text for this item Link to SFX for this item
2. Haince, Jean-François F. "Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy." Trends in molecular medicine 11.10 (2005): 456-63. Link to SFX for this item
3. Futreal, P Andrew A. "A census of human cancer genes." Nature reviews. Cancer 4.3 (2004): 177-183. Link to Full Text for this item Link to SFX for this item
4. Curtin, N J J. "The role of PARP in DNA repair and its therapeutic exploitation." British Journal of Cancer 105.8 (2011): 1114-1122. Link to Full Text for this item Link to SFX for this item
5. Noble, Martin E M E. "Protein kinase inhibitors: insights into drug design from structure." Science 303.5665 (2004): 1800-5. Link to SFX for this item
6. Knesl, P. "Improved synthesis of substituted 6,7-dihydroxy-4-quinazolineamines: Tandutinib, erlotinib and gefitinib." Molecules 11.4 (2006): 286-297. Link to Full Text for this item Link to SFX for this item
7. Kamb, A. "Why is cancer drug discovery so difficult?" Nature reviews. Drug discovery 6.2 (2007): 115-20. Link to Full Text for this item Link to SFX for this item
8. Branzei, D. "Regulation of DNA repair throughout the cell cycle." Nature reviews. Molecular cell biology 9.4 (2008): 297-308. Link to Full Text for this item Link to SFX for this item
9. Helleday, T. "DNA double-strand break repair: From mechanistic understanding to cancer treatment." DNA repair 6.7 (2007): 923-935. Link to SFX for this item
10. Phatak, P. "Telomerase and its potential for therapeutic intervention." British journal of pharmacology 152.7 (2008): 1003-11. Link to Full Text for this item Link to SFX for this item
11. Sinha, Rajeshwar P P. "UV-induced DNA damage and repair: a review." Photochemical & photobiological sciences 1.4 (2002): 225-236. Link to Full Text for this item Link to SFX for this item
12. Jagtap, P. "Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors." Nature reviews. Drug discovery 4.5 (2005): 421-40. Link to Full Text for this item Link to SFX for this item
13. Clements, E. "The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website." The British Journal of Cancer 91.2 (2004): 355-358. Link to Full Text for this item Link to SFX for this item
14. Ratnam, K. "Current Development of Clinical Inhibitors of Poly(ADP-Ribose) Polymerase in Oncology." Clinical cancer research 13.5 (2007): 1383-1388. Link to SFX for this item
15. Krishnakumar, R. "Reciprocal Binding of PARP-1 and Histone H1 at Promoters Specifies Transcriptional Outcomes." Science 319.5864 (2008): 819-21. Link to SFX for this item
16. Longley, Daniel B B. "5-fluorouracil: mechanisms of action and clinical strategies." Nature reviews. Cancer 3.5 (2003): 330-8. Link to Full Text for this item Link to SFX for this item
17. Esteller, M. "Epigenetics in cancer." New England Journal of Medicine, The 358.11 (2008): 1148-1159. Link to SFX for this item
18. Khanna, K K K. "DNA double-strand breaks: signaling, repair and the cancer connection." Nature genetics 27.3: 247-254. Link to SFX for this item
19. Hahn, R A C. "Creation of human tumour cells with defined genetic elements." Nature 400.6743 (1999): 464-468. Link to Full Text for this item Link to SFX for this item
20. Hartigan, J. "The Consensus Coding Sequences of Human Breast and Colorectal Cancers." Science 314.5797 (2006): 268-74. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.